These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3339333)

  • 1. Identification of haemagglutinin-neuraminidase antibody binding sites by Western blot analysis of antibody-resistant mutants and partial digest fragments of Newcastle disease virus.
    Samson AC; Nesbit M; Lyon AM; Meulemans G
    J Gen Virol; 1988 Feb; 69 ( Pt 2)():473-80. PubMed ID: 3339333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anomalous behaviour of Newcastle disease virus haemagglutinin-neuraminidase protein in Western blotting analysis of monoclonal antibody binding sites.
    Samson AC
    J Gen Virol; 1986 Jun; 67 ( Pt 6)():1199-203. PubMed ID: 2423638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Location of a neutralizing epitope for the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus.
    Chambers P; Nesbit M; Yusoff K; Millar NS; Samson AC; Emmerson PT
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():2115-22. PubMed ID: 2457068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of monoclonal antibody-resistant mutants of Newcastle disease virus.
    Samson AC; Russell PH; Hallam SE
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():357-61. PubMed ID: 3838186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synergistic neutralization of Newcastle disease virus by two monoclonal antibodies to its haemagglutinin-neuraminidase protein.
    Russell PH
    Arch Virol; 1986; 90(1-2):135-44. PubMed ID: 3729723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a variable epitope on the Newcastle disease virus hemagglutinin-neuraminidase protein.
    Hu S; Wang T; Liu Y; Meng C; Wang X; Wu Y; Liu X
    Vet Microbiol; 2010 Jan; 140(1-2):92-7. PubMed ID: 19729254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies.
    Orvell C; Rydbeck R; Löve A
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1929-39. PubMed ID: 3018131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parainfluenza virus type 2 haemagglutinin-neuraminidase glycoprotein characterized with monoclonal antibodies.
    Rydbeck R; Löve A; Orvell C
    J Gen Virol; 1988 Apr; 69 ( Pt 4)():931-5. PubMed ID: 2451708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation within a neutralizing domain on the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus.
    Iorio RM; Borgman JB; Glickman RL; Bratt MA
    J Gen Virol; 1986 Jul; 67 ( Pt 7)():1393-403. PubMed ID: 2425048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of amino acid substitutions on glycosylation of the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus strain Beaudette C.
    Yusoff K; Nesbit M; Samson AC; Emmerson PT
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1549-52. PubMed ID: 2471815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent viral attachment.
    Iorio RM; Glickman RL; Riel AM; Sheehan JP; Bratt MA
    Virus Res; 1989 Jul; 13(3):245-61. PubMed ID: 2475989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt.
    Moharam I; Asala O; Reiche S; Hafez H; Beer M; Harder T; Grund C
    Virol J; 2021 Apr; 18(1):86. PubMed ID: 33902633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of three antigenic sites on the haemagglutinin-neuraminidase protein of Newcastle disease virus.
    Yusoff K; Nesbit M; McCartney H; Emmerson PT; Samson AC
    Virus Res; 1988 Nov; 11(4):319-33. PubMed ID: 2464879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of monoclonal antibodies to Newcastle disease virus in passive immunization.
    Umino Y; Kohama T; Sato TA; Sugiura A
    J Gen Virol; 1990 May; 71 ( Pt 5)():1199-203. PubMed ID: 2345369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies against the glycoproteins of mumps virus: fusion inhibition by anti-HN monoclonal antibody.
    Tsurudome M; Yamada A; Hishiyama M; Ito Y
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2259-65. PubMed ID: 3760826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and characterization of monoclonal antibodies to Newcastle Disease Virus.
    Kumar GR; Saxena S; Sahoo AP; Chaturvedi U; Kumar S; Santra L; Desai GS; Singh L; Tiwari AK
    Indian J Exp Biol; 2016 Mar; 54(3):180-6. PubMed ID: 27145631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newcastle disease virus: the effect of monoclonal antibody in the overlay on virus penetration and the immunoselection of variants.
    Russell PH
    J Gen Virol; 1984 Apr; 65 ( Pt 4)():795-8. PubMed ID: 6546769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of fusion by neutralizing monoclonal antibodies to the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus.
    Iorio RM; Glickman RL; Sheehan JP
    J Gen Virol; 1992 May; 73 ( Pt 5)():1167-76. PubMed ID: 1375279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of monoclonal antibodies against parainfluenza virus type 3-induced brain infection in hamsters.
    Rydbeck R; Löve A; Norrby E
    J Gen Virol; 1988 May; 69 ( Pt 5)():1019-24. PubMed ID: 2836547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to three structural proteins of Newcastle disease virus: biological characterization with particular reference to the conformational change of envelope glycoproteins associated with proteolytic cleavage.
    Umino Y; Kohama T; Sato TA; Sugiura A; Klenk HD; Rott R
    J Gen Virol; 1990 May; 71 ( Pt 5)():1189-97. PubMed ID: 1693166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.